Alnylam Pharmaceuticals: Wells Fargo cuts target price to $253 from $256
ALNY•Wells Fargo cut its target price for Alnylam Pharmaceuticals to $253 from $256.
Related News
FF EAI Robotics Ecosystem agrees to buy Faraday Future robotics assets valued at about $200 million
FFAI•
Saudi Aramco headquarters suffered extensive damage in Houthi attack, sources say
USO•
Edible Garden becomes primary herb supplier at UNFI Mid-Atlantic distribution center
EDBL•
Bank of America misses profit estimates on capital market weakness; books $1.2 billion charge
BAC•
Jasper Therapeutics: William Blair resumes coverage with outperform rating
JSPR•